Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 4,430 shares at $98.18 ($435K) on 2020-01-22, disclosed to the SEC on 2020-01-24.
Seasonal sale ($435k) by Chief Financial Officer — this insider has traded NVCR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.11 | 1,515 | $149K | 34.2% |
| 2 | $98.11 | 1,515 | $149K | 34.2% |
| 3 | $98.18 | 1,400 | $137K | 31.6% |
| Total | $98.13 avg | 4,430 | $435K | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |